Why we should measure and treat apoB.

57:14
Responsible evaluation and deployment of AI in cardiology with Dr. Sneha Shah Jain

1:03:03
Cholesterol: The Good, The Bad, and Lipoprotein (a)

56:00
The Revascularization Choices Among Under-Represented Grps Eval(The RECHARGE Trials Prog)Dr. Gaudino

23:11
Congestive Heart Failure (CHF) Pathophysiology, Nursing, Treatment, Symptoms | Heart Failure Part 1

33:41
Lipoprotein(a): Who's Most at Risk

50:56
PREVENT-ing CVD with the novel AHA PREVENT Equations: New Year, New Insights. Sadiya Sana Khan, MD

23:59
Cardiovascular | Cardiac Cycle

36:38